SPDR® S&P Biotech ETF (XBI)

Tuesday’s Trading Day
252.24 +10.61 / +4.39%
As of Jun 30
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
254.70 +2.46 / +0.98%
Volume: 6.9K

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+6.01% 3 years+42.73%
3 months+14.60% 5 years+37.77%
1 year+65.34% Since inception+19.32%
Data through 07/01/2015

Quote Details

Previous close$241.63
Open day’s range245.03 – 253.08
Net asset value (NAV)252.34 (06/30/2015)
Daily volume2,425,289
Average volume (3 months)1,091,804
Data as of 06/30/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+37.77%+22.89%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.321.68
Net assets$2.3B$1.9B
Average market cap$2.4B$38.6B
Average P/E--24.7
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
PPH Market Vectors® Pharmaceutical ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 1.97%
SRPT Sarepta Therapeutics Inc1.80%
ALDR Alder Biopharmaceuticals Inc1.66%
BLUE bluebird bio Inc1.60%
DYAX Dyax Corp1.51%
RARE Ultragenyx Pharmaceutical Inc1.50%
ESPR Esperion Therapeutics Inc1.43%
PRTA Prothena Corporation PLC1.36%
MNTA Momenta Pharmaceuticals Inc1.32%
FOLD Amicus Therapeutics Inc1.32%

To view my watchlist

Not a member yet?

Sign up now for a free account